title: CAPD in patients with autosomal dominant polycystic kidney disease.
abstract: OBJECTIVE
  To investigate whether there are specific complications to continuous ambulatory peritoneal dialysis (CAPD) in patients with autosomal dominant polycystic kidney disease (ADPKD) due to defects in various wall structures--causing hernia and diverticulitis--and to enlarged kidneys.
  
  
  METHODS
  The clinical experience of CAPD in 26 patients with ADPKD, treated for 11+/-6 months, was studied in retrospect and compared with that of 26 contemporary controls. Medical records were reviewed with respect to survival in this treatment form and any complication. Peritoneal dialysis capacity (PDC), as measured in 21 ADPKD patients and 20 controls, was also evaluated.
  
  
  METHODS
  University Hospital.
  
  
  RESULTS
  Before initiation of CAPD, enlarged kidneys necessitated nephrectomy in 2 of 26 ADPKD patients; both cases were registered as preparation for transplantation, not for CAPD. Survival in CAPD was similar in ADPKD patients and controls. Hernia was present in 4 ADPKD patients and 2 controls, and required transfer to hemodialysis in 1 patient from each group, temporarily. The incidence of peritonitis was 1 per 20 months in ADPKD patients versus 1 in 27 months in the controls, not significantly different. Peritonitis was caused by colonic bacteria in similar numbers. Residual renal function was 1.9 2.1 mL/min per 1.73 m2 in ADPKD patients versus 1.9+/-1.4 mL/min per 1.73 m2 in the controls. No difference was detected in any of the variables measured by PDC.
  
  
  CONCLUSIONS
  There were no specific problems related to ADPKD.
authors.affiliation: Department of Nephrology, Sahlgrenska Universitetssjukhuset, Göteborg, Sweden.
authors.forename: H
authors.initials: H
authors.lastname: Hadimeri
authors.forename: A C
authors.initials: AC
authors.lastname: Johansson
authors.forename: B
authors.initials: B
authors.lastname: Haraldsson
authors.forename: G
authors.initials: G
authors.lastname: Nyberg
mesh_terms: D000206:Actuarial Analysis; D015992:Body Mass Index; D001835:Body Weight; D003106:Colon / Q000382:microbiology; D004239:Diverticulitis, Colonic / Q000209:etiology; D004927:Escherichia coli Infections; D005260:Female; D005500:Follow-Up Studies; D006555:Hernia, Ventral / Q000209:etiology; D006801:Humans; D015994:Incidence; D007710:Klebsiella Infections; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects / Q000379:methods; D010538:Peritonitis / Q000209:etiology / Q000382:microbiology; D016891:Polycystic Kidney, Autosomal Dominant / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D011552:Pseudomonas Infections; D006435:Renal Dialysis; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome